NASDAQ Losers: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Himax Technologies, Inc. (NASDAQ:HIMX), Blue Earth Inc. (NASDAQ:BBLU), Omeros Corporation (NASDAQ:OMER), Net Element International Inc (NASDAQ:NETE)

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases, announced the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania (Penn); Inovio Pharmaceuticals; and MedImmune, the global biologics research and development arm of AstraZeneca. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) belongs to Healthcare sector. Its weekly performance is 5.58%. On last trading day company shares ended up $11.55. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) distance from 50-day simple moving average (SMA50) is 11.02%.

Himax Technologies, Inc. (NASDAQ:HIMX) announced that Google Inc. has decided not to exercise its previously issued purchase option to make an additional investment into Himax’s subsidiary, Himax Display Inc. (“HDI”). Himax Technologies, Inc. (NASDAQ:HIMX) shares moved down -7.92% in last trading session and ended the day at $8.02. HIMX Gross Margin is 24.80% and its return on assets is 8.90%. Himax Technologies, Inc. (NASDAQ:HIMX) quarterly performance is 38.04%.

Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Blue Earth Inc. (NASDAQ:BBLU) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by the Company concerning Blue Earth’s business and financial prospects. On 21 October, Blue Earth Inc. (NASDAQ:BBLU) shares moved down -50.00% and was closed at $1.29. BBLU EPS growth in last 5 year was -37.30%. Blue Earth Inc. (NASDAQ:BBLU) year to date (YTD) performance is -52.57%.

Omeros Corporation (NASDAQ:OMER) said it suspended enrolment in a mid-stage study testing its experimental Huntington’s drug as the company evaluates data from a concurrent trial in rats, sending its shares down 10 percent before the bell. Omeros Corporation (NASDAQ:OMER) ended the last trading day at $12.12. Company weekly volatility is calculated as 9.01% and price to cash ratio as 11.01. Omeros Corporation (NASDAQ:OMER) showed a weekly performance of -1.30%.

Net Element International Inc (NASDAQ:NETE) Releases Open Letter to Shareholders. We kicked off a series of milestones in the month of September by announcing that we will integrate the Apple (AAPL) Pay service offering into our point-of-sale payment acceptance hardware and software via Apple iPhone 6, iPhone 6 Plus and Apple Watch devices. Aligning Net Element’s services with one of the most reputable companies in the world is an achievement from which we expect to have long-term benefit. Net Element International Inc (NASDAQ:NETE) shares moved down -5.85% in last trading session and ended the day at $1.61. NETE Gross Margin is 27.70% and its return on assets is -128.60%. Net Element International Inc (NASDAQ:NETE) quarterly performance is -25.12%.